Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...

UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...

The Joint Department of Biomedical Engineering, a collaboration between NC State and UNC-CH, received a $20 million ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Mukesh Ambani-led Reliance has acquired Velvette, an iconic FMCG brand known for its innovative sachet packaging, from ...

MARKET watchers believe tax incentives proposed by the Monetary Authority of Singapore’s (MAS) equities market review group ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Barry Snyder, left, chief technology officer for AI event-planning startup platform Eventio, and CEO Erin Kerner are shown at ...